XT
RNTX

XTX Topco’s Rein Therapeutics RNTX Stock Holding History

XTX Topco’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.6K Buy
45,760
+12,836
+39% +$15.5K ﹤0.01% 3728
2026
Q1 		$42.8K Buy
+32,924
New +$40.8K ﹤0.01% 3358
2025
Q4 		– Sell
-14,984
Closed -$17.2K – 3948
2025
Q3 		$17.2K Buy
+14,984
New +$19K ﹤0.01% 2357
2025
Q1 		– Sell
-16,038
Closed -$36.9K – 3265
2024
Q4 		$36.9K Buy
+16,038
New +$48.6K ﹤0.01% 1944

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

XTX Topco's RNTX Position: Q2 2026 in Review

XTX Topco increased its Rein Therapeutics (RNTX) stake by 39% in Q2 2026, buying an estimated $15.5K and bringing the position to 45,760 shares worth $47.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3728.

XTX Topco first reported a position in RNTX in Q4 2024 and has held it in 4 quarters since. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • XTX Topco held 45,760 shares of Rein Therapeutics worth $47.6K as of Q2 2026.
  • XTX Topco bought 12,836 Rein Therapeutics shares in Q2 2026, an estimated $15.5K.
  • Rein Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3728 holding.
  • XTX Topco first reported a position in Rein Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.